Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
Author:
Funder
Canadian Institutes of Health Research
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology
Reference133 articles.
1. Discovery, characterization, and clinical development of the glucagon-like peptides;Drucker;Journal of Clinical Investigation,2017
2. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes;Schauer;New England Journal of Medicine,2017
3. Mechanisms of NAFLD development and therapeutic strategies;Friedman;Nature Medicine,2018
4. Comparison of human and murine enteroendocrine cells by transcriptomic and peptidomic profiling;Roberts;Diabetes,2019
5. High-resolution mRNA and secretome atlas of human enteroendocrine cells;Beumer;Cell,2020
Cited by 182 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Principal components analysis on genes related to inflammasome complex and microglial activation in the hypothalamus of obese mice treated with semaglutide (GLP-1 analog);Brain Research;2025-01
2. Isoquinoline small molecule ligands are agonists and probe-dependent allosteric modulators of the glucagon subfamily of GPCRs;Biochemical Pharmacology;2024-11
3. Tirzepatide shows neuroprotective effects via regulating brain glucose metabolism in APP/PS1 mice;Peptides;2024-09
4. Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management;Expert Review of Endocrinology & Metabolism;2024-08-28
5. Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial;Journal of Diabetes Investigation;2024-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3